Gursimran Kaur, PharmD

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India

Poster(s):

• (307) Cardiovascular Adverse Events Associated with PARP Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (233) Cytomegalovirus Infection Reactivation in Multiple Myeloma Patients Administered Proteasome Inhibitor-Combination Therapy: A Disproportionality Analysis in a Spontaneous Reporting Database
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (228) Gastrointestinal Adverse Events Associated with Hedgehog Pathway Inhibitors: A Real-World Pharmacovigilance Study
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (312) Gastrointestinal Adverse Events Associated with PI3K Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (232) Purine Antimetabolites Associated with Pneumocystis Jiroveci Pneumonia: A Disproportionality Analysis in a Spontaneous Reporting Database
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (170) Pulmonary Related Adverse Events Associated with Bruton's Tyrosine Kinase Inhibitor: A Disproportionality Analysis in a Spontaneous Reporting Database
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (230) Tumor Lysis Syndrome Associated with Bruton's Tyrosine Kinase Inhibitor: A Disproportionality Analysis in a Spontaneous Reporting Database
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST